Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding , have raised $217 million in venture capital to start a new company, Denali […]
Featured Posts
In the five years since the first DrugBaron article was published, entitled “Hard Times, Harder Times,” it seems that in the business of drug discovery and development everything has changed – […]
Literally millions of people take vitamins in the hopes that doing so will improve their health – but scientific evidence has pointed to vitamin supplementation being useless or worse. Beta […]
Two months ago, the biotechnology company Orexigen filed a patent claiming its weight-loss drug Contrave might prevent heart attacks based on the first 25% of data from an ongoing study. […]
In April of 2014, GSK and Novartis announced a swap of assets, with GSK acquiring the Novartis global Vaccines business (excluding influenza vaccines) and Novartis gaining the GSK Oncology business. […]
Marks Second FDA Fast Track Designation for Evofosfamide, an Investigational Compound Currently in Phase 3 Clinical Trials SOUTH SAN FRANCISCO, CA–(Marketwired – May 12, 2015) – Threshold Pharmaceuticals, Inc. (NASDAQ: […]
DALLAS, TX–(Marketwired – May 11, 2015) – Vivione Biosciences Inc. (“Vivione” or the “Company”) (TSX VENTURE: VBI), is pleased to announce a research collaboration with Northwestern University Feinberg School of […]
Scientists in the Netherlands were able to make mice fat just by exposing them to 24 hours a day of artificial light. The fat mice didn’t eat more or exercise […]
An “earworm” is a song that won’t stop playing in your head. It’s annoying for sure, and if it goes on too long the effect can be a bit maddening. […]
REDUCE-IT Cardiovascular Outcomes Study Continuing on Schedule; Product Revenue Increased 42% Over Same Period Last Year; Conference Call Set for 8:00 a.m. EST Today BEDMINSTER, NJ, and DUBLIN, IRELAND–(Marketwired – […]